Fibromyalgia and COVID-19: Risks, Symptom Overlap, Management, and Vaccination Guidance

Increased Vulnerability

Fibromyalgia (FM) involves central sensitization and dysregulated stress/immune axes. While not classically "immunocompromised," patients may have altered immune responses and higher rates of comorbidities (obesity, autoimmune conditions) that increase severe COVID-19 risk.

Symptom Overlap and Differentiation

SymptomFibromyalgiaCOVID-19
FatigueChronic, unrefreshing sleepAcute, often with fever
Body achesWidespread, migratoryMyalgia, often with respiratory signs
HeadacheCommon (tension/migraine)Common
FeverRare (low-grade if any)Frequent, often >100.4°F
Respiratory symptomsAbsentCough, dyspnea, sore throat
Loss of taste/smellAbsentHighly specific

Management If Infected

  • Contact your rheumatologist and primary care provider immediately.
  • Continue FM medications unless advised otherwise (do not abruptly stop immunosuppressants).
  • Hydrate, rest, monitor temperature and oxygen saturation.
  • Use acetaminophen for fever/pain; avoid NSAIDs if contraindicated.
  • Isolate per CDC guidelines; notify close contacts.

Vaccination

COVID-19 vaccines are strongly recommended for FM patients. mRNA vaccines (Pfizer/Moderna) are safe and effective. Time vaccination during stable disease if possible. Discuss timing with your provider if on rituximab or high-dose steroids (may blunt response). Boosters per current CDC schedule.

Ongoing Precautions

  • Mask in high-risk settings (crowded indoor, healthcare).
  • Hand hygiene, ventilation.
  • Prioritize mental health: telehealth, support groups, CBT for health anxiety.
  • Maintain FM self-care: pacing, sleep hygiene, gentle movement.

Stay informed via CDC, ACR, and your healthcare team. Individual risk varies—personalized guidance is essential.

Viral Infections - Related Articles